Drug Profile
Research programme: antibacterials - Array BioPharma
Alternative Names: AR 00380547Latest Information Update: 02 Aug 2019
Price :
$50
*
At a glance
- Originator Array BioPharma
- Class
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 30 Jul 2019 Array Biopharma has been acquired by Pfizer
- 10 Aug 2011 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 23 Feb 2007 Preclinical trials in Bacterial infections in USA (unspecified route)